Ignite Creation Date:
2024-05-06 @ 4:31 PM
Last Modification Date:
2024-10-26 @ 2:11 PM
Study NCT ID:
NCT05010122
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2021-07-22
Brief Title:
ASTX727 Venetoclax and Gilteritinib for the Treatment of Newly Diagnosed Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Sponsor:
Organization:
MD Anderson Cancer Center